COVID-19 Vaccine Elicits Antibodies that Neutralize Coronavirus Mutations

In COVID-19, Latest News by Precision Vaccinations

The results from an in vitro study conducted by the University of Texas Medical Branch (UTMB) and Pfizer shows the antibodies from people who have received the Comirnaty COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains.
This study’s findings, published on January 7, 2021, are crucial as rapidly spreading variants of SARS-CoV-2 coronavirus have been reported in various countries, including the United Kingdom and the USA.

Read More